Xenon Reports Q2 2024 Financial Results and Business Update
08 Aug 2024 //
GLOBENEWSWIRE
Xenon Pharma: Phase 2 Azetukalner Data In Depression At ASCP 2024
28 May 2024 //
GLOBENEWSWIRE
Polarean`s Xenon MRI to be Featured at Upcoming ATS 2024 Conference
08 May 2024 //
GLOBENEWSWIRE
Xenon Q1 2024 Call/Webcast, Corporate Update
02 May 2024 //
GLOBENEWSWIRE
Xenon finally finds a way forward with epilepsy win
04 Oct 2021 //
EVALUATE
Xenon Announces Positive Topline Results from Phase 2b ‘X-TOLE’ Trial of XEN1101
04 Oct 2021 //
GLOBENEWSWIRE
Xenon finally finds a way forward with epilepsy win
04 Oct 2021 //
EVALUATE
Xenon Announces Positive Topline Results from Phase 2b ‘X-TOLE’ Trial of XEN1101
04 Oct 2021 //
GLOBENEWSWIRE
Xenon to Participate at the William Blair Biotech Focus Conference 2021
13 Jul 2021 //
GLOBENEWSWIRE
Xenon’s Teva-partnered pain drug flunks another test
27 Jun 2017 //
FIERCE BIOTECH